William Blair Estimates Beauty Health FY2024 Earnings

The Beauty Health Company (NASDAQ:SKIN) – Equities researchers at William Blair issued their FY2024 EPS estimates for Beauty Health in a research report issued on Wednesday, November 13th. William Blair analyst M. Andrew anticipates that the company will post earnings per share of ($0.29) for the year. The consensus estimate for Beauty Health’s current full-year earnings is ($0.25) per share. William Blair also issued estimates for Beauty Health’s FY2025 earnings at ($0.43) EPS.

A number of other equities analysts have also commented on the stock. Piper Sandler reaffirmed an “underweight” rating and set a $1.00 target price (down from $1.50) on shares of Beauty Health in a research report on Friday, August 9th. Canaccord Genuity Group raised their target price on shares of Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. Finally, Stifel Nicolaus cut their price objective on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a report on Friday, July 26th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Beauty Health presently has a consensus rating of “Hold” and a consensus price target of $2.55.

Beauty Health Stock Performance

Shares of NASDAQ:SKIN opened at $1.53 on Monday. The firm has a market cap of $189.75 million, a PE ratio of -3.64 and a beta of 0.90. The firm’s 50 day simple moving average is $1.57 and its 200-day simple moving average is $1.86. Beauty Health has a one year low of $0.91 and a one year high of $5.17. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.47 and a current ratio of 6.56.

Institutional Investors Weigh In On Beauty Health

Institutional investors have recently bought and sold shares of the company. Caprock Group LLC acquired a new stake in Beauty Health in the second quarter valued at approximately $38,000. Sanctuary Advisors LLC acquired a new stake in Beauty Health in the second quarter valued at approximately $47,000. SG Americas Securities LLC acquired a new stake in Beauty Health in the third quarter valued at approximately $37,000. Orion Portfolio Solutions LLC acquired a new stake in Beauty Health in the third quarter valued at approximately $65,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in Beauty Health in the first quarter valued at approximately $200,000. 93.26% of the stock is currently owned by institutional investors and hedge funds.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.